Skip Navigation

Noah Lechtzin, M.D., M.H.S.

Headshot of Noah Lechtzin
  • Director, Adult Cystic Fibrosis Program
  • Associate Professor of Medicine


Amyotrophic Lateral Sclerosis (ALS), Cystic Fibrosis, Pulmonary and Critical Care Medicine more

Research Interests

The metabolic complications in CF, including vitamin D deficiency, osteoporosis and testosterone deficiency; The impact of antibiotic resistant bacterial infections in CF patients more


The Johns Hopkins Hospital

1830 E. Monument Street
1830 Building 5th Floor Pulmonary
Baltimore, MD 21287 map
Phone: 410-502-7044 | Fax: 410-502-7048

Johns Hopkins Outpatient Center (now called Levi Watkins, Jr., M.D., Outpatient Center)

Appointment Phone: 410-955-3467
601 N. Caroline St.
Baltimore, MD 21287 map


Dr. Lechtzin is a pulmonary and critical care medicine physician. He directs the Adult CF program and the neuromuscular pulmonary clinic at Johns Hopkins and is an expert in the treatment of cystic fibrosis, pulmonary complications of neuromuscular disease and the care of critically ill patients in the Medical ICU. He is a member of the Longcope Firm Faculty and provides teaching to medical students and residents at Johns Hopkins. more


  • Director, Adult Cystic Fibrosis Program
  • Associate Professor of Medicine
  • Associate Professor of Neurology

Departments / Divisions

Centers & Institutes



  • MD; Medicine; Temple University School of Medicine (1994)


  • Medicine; Johns Hopkins University School of Medicine (1997)


  • Pulmonary Medicine; Johns Hopkins University School of Medicine (2001)

Board Certifications

  • American Board of Internal Medicine (Critical Care Medicine) (2001)
  • American Board of Internal Medicine (Internal Medicine) (1997)
  • American Board of Internal Medicine (Pulmonary Disease) (2000)

Research & Publications

Research Summary

Dr. Lechtzin has a master’s degree in clinical epidemiology and conducts clinical research related to cystic fibrosis and also neuromuscular disease. Particular interests include the development of new therapies for cystic fibrosis, understanding the impact of pain in CF, and studying the impact of resistant infections in people with CF.

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button